rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-3-17
|
pubmed:abstractText |
We tested the response of stress-activated mitogen-activated protein kinases (MAPKs) - p38 MAPK and c-JUN NH2-terminal kinase (JNK) - following hypoxia-ischemia (H-I) induced by unilateral carotid artery ligation and hypoxia (8% O2 and 92% N2) for 2.5 h in postnatal-day-7 rats. Phosphorylation of p38 MAPK increased in the hippocampus and cortex immediately following H-I and returned to a basal level 6 h later. In contrast to p38 MAPK, phosphorylation of JNK decreased in the hippocampus and cortex immediately following H-I. Intracerebroventricular administration of two different p38 MAPK inhibitors prior to H-I significantly protected the neonatal brain from H-I injury. Interestingly, p38 MAPK inhibitors did not attenuate caspase-3 activation 24 h after H-I. Thus, these data suggest that p38 MAPKs contribute to the rapid, early component of brain injury following neonatal H-I.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Casp3 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/SB 203580,
http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0378-5866
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
405-10
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12640179-Animals,
pubmed-meshheading:12640179-Animals, Newborn,
pubmed-meshheading:12640179-Blotting, Western,
pubmed-meshheading:12640179-Brain,
pubmed-meshheading:12640179-Caspase 3,
pubmed-meshheading:12640179-Caspases,
pubmed-meshheading:12640179-Enzyme Inhibitors,
pubmed-meshheading:12640179-Hypoxia-Ischemia, Brain,
pubmed-meshheading:12640179-Imidazoles,
pubmed-meshheading:12640179-Injections, Intraventricular,
pubmed-meshheading:12640179-Mitogen-Activated Protein Kinases,
pubmed-meshheading:12640179-Neuroprotective Agents,
pubmed-meshheading:12640179-Phosphorylation,
pubmed-meshheading:12640179-Pyridines,
pubmed-meshheading:12640179-Rats,
pubmed-meshheading:12640179-Rats, Sprague-Dawley,
pubmed-meshheading:12640179-p38 Mitogen-Activated Protein Kinases
|
pubmed:year |
2002
|
pubmed:articleTitle |
Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injury.
|
pubmed:affiliation |
Department of Pharmacy, Ewha Women's University College of Pharmacy, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|